ESG risk score 24.53
Environmental score -
Social score -
Governance score -
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Pharma Mar SA
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol PHM:xmce
Currency EUR
BME Spanish Exchanges
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 21.5%
1 year 14.54%
3 years 105.79%
Data provided by 
Key stats
Price/earnings (LTM) 21.2
Dividend yield (LTM) 0.89%
EPS (LTM) 4.29
Volatility (30 days) -
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Pharma Mar SA
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
Sector Healthcare
Industry -
Market cap 1bn
Data provided by /
/ Frequently asked questions
To buy Pharma Mar SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pharma Mar SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pharma Mar SA is PHM:xmce. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pharma Mar SA has its primary listing on BME Spanish Exchanges. You can trade Pharma Mar SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pharma Mar SA is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Pharma Mar SA as part of a broader investment portfolio.